Geode Capital Management
THRN

Geode Capital Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Geode Capital Management’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-314,864
Closed -$3.21M – 4792
2023
Q3 		$3.21M Buy
314,864
+64,912
+26% +$494K ﹤0.01% 2867
2023
Q2 		$1.17M Buy
249,952
+5,384
+2% +$24.7K ﹤0.01% 3285
2023
Q1 		$1.13M Buy
244,568
+22,189
+10% +$97.6K ﹤0.01% 3289
2022
Q4 		$807K Buy
222,379
+10,253
+5% +$45.5K ﹤0.01% 3455
2022
Q3 		$1M Buy
212,126
+30,850
+17% +$155K ﹤0.01% 3381
2022
Q2 		$877K Buy
181,276
+54,195
+43% +$329K ﹤0.01% 3489
2022
Q1 		$808K Buy
127,081
+82,126
+183% +$442K ﹤0.01% 3711
2021
Q4 		$279K Buy
+44,955
New +$351K ﹤0.01% 4330

Geode Capital Management's THRN Position: Q4 2023 in Review

Geode Capital Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 314,864 shares — an estimated $3.21M sold.

Geode Capital Management first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $3.21M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

  • Geode Capital Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 314,864 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $3.21M.
  • Geode Capital Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Geode Capital Management's Thorne Healthtech, Inc. Common Stock position peaked at $3.21M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.